These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
589 related items for PubMed ID: 7847036
41. [Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)]. Angelkort B, Stürner KH. Dtsch Med Wochenschr; 1979 Feb 02; 104(5):182-6. PubMed ID: 759178 [Abstract] [Full Text] [Related]
42. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Lozier JN, Santagostino E, Kasper CK, Teitel JM, Hay CR. Semin Hematol; 1993 Apr 02; 30(2 Suppl 1):10-21. PubMed ID: 8480192 [Abstract] [Full Text] [Related]
43. The development and characterisation of antibodies to human factor VIII in haemophilic dogs. Littlewood JD, Barrowcliffe TW. Thromb Haemost; 1987 Jun 03; 57(3):314-21. PubMed ID: 3116702 [Abstract] [Full Text] [Related]
44. Dose requirement for replacement therapy in hemophilia A. Allain JP. Thromb Haemost; 1979 Oct 31; 42(3):825-31. PubMed ID: 505399 [Abstract] [Full Text] [Related]
45. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors. Leissinger CA, Becton DL, Ewing NP, Valentino LA. Haemophilia; 2007 May 31; 13(3):249-55. PubMed ID: 17498073 [Abstract] [Full Text] [Related]
46. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII. Kantrowitz JL, Lee ML, McClure DA, Kingdon HS, Thomas WR. Clin Ther; 1987 May 31; 9(4):405-19. PubMed ID: 3111706 [Abstract] [Full Text] [Related]
49. Prothrombin complex concentrates in hemophiliacs with inhibitors--a multicenter therapeutic trial. Lusher JM, Shapiro SS, Palascak JE, Rao AV, Levine PH, Blatt PM. Trans Assoc Am Physicians; 1980 May 31; 93():175-81. PubMed ID: 6787773 [No Abstract] [Full Text] [Related]
50. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A. Sullivan DW, Purdy LJ, Billingham M, Glader BE. Pediatrics; 1984 Aug 31; 74(2):279-81. PubMed ID: 6431390 [Abstract] [Full Text] [Related]
51. [Management of hemophilia]. Laurian Y. Rev Prat; 1989 Dec 21; 39(30):2669-73. PubMed ID: 2515580 [Abstract] [Full Text] [Related]
52. Management of haemophilia in Sweden. Nilsson IM. Thromb Haemost; 1976 Jun 30; 35(3):510-21. PubMed ID: 989956 [Abstract] [Full Text] [Related]
53. Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand. Lloyd JV, Street AM, Berry E, McPherson J, Ekert H, Lammi A, McWhirter WR, Duncan EM, Maxwell EL, Rowell J, Baker RI, Leahy MF, Jupe D. Aust N Z J Med; 1997 Dec 30; 27(6):658-64. PubMed ID: 9483232 [Abstract] [Full Text] [Related]
55. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor. Karayalcin G, Goldberg B, Cherrick I, Kurer C, Bierman F, Lanzkowsky P. Am J Pediatr Hematol Oncol; 1993 Nov 30; 15(4):416-9. PubMed ID: 8214364 [Abstract] [Full Text] [Related]
59. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate. Peerlinck K, Arnout J, Di Giambattista M, Gilles JG, Laub R, Jacquemin M, Saint-Remy JM, Vermylen J. Thromb Haemost; 1997 Jan 30; 77(1):80-6. PubMed ID: 9031454 [Abstract] [Full Text] [Related]